SciBase Holding AB (publ)
STO:SCIB
Relative Value
The Relative Value of one SCIB stock under the Base Case scenario is 0.333 SEK. Compared to the current market price of 0.266 SEK, SciBase Holding AB (publ) is Undervalued by 20%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SCIB Competitors Multiples
SciBase Holding AB (publ) Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
S
|
SciBase Holding AB (publ)
STO:SCIB
|
220.3m SEK | 6 | -2.4 | -2.3 | -2.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
190.8B USD | 4.3 | 29.3 | 16.8 | 23 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.9B USD | 17.3 | 61 | 46.3 | 56.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
139.8B USD | 5.6 | 43 | 21.8 | 26.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
116.7B USD | 3.3 | 25.3 | 13.9 | 20.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.2B USD | 5.3 | 36.7 | 21.5 | 28.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
44.7B EUR | 1.9 | 21.3 | 11.8 | 16.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
48.5B USD | 11.3 | 45.7 | 32.5 | 35.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.7B USD | 7.9 | 44.4 | 24.4 | 26.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48B USD | 2.2 | 27.2 | 10.6 | 17.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.8B USD | 6.8 | 24.8 | 17.5 | 19.4 |